<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.3.340">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>sss-tumorleri</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
</style>


<script src="sss-tumorleri_files/libs/clipboard/clipboard.min.js"></script>
<script src="sss-tumorleri_files/libs/quarto-html/quarto.js"></script>
<script src="sss-tumorleri_files/libs/quarto-html/popper.min.js"></script>
<script src="sss-tumorleri_files/libs/quarto-html/tippy.umd.min.js"></script>
<script src="sss-tumorleri_files/libs/quarto-html/anchor.min.js"></script>
<link href="sss-tumorleri_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="sss-tumorleri_files/libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="sss-tumorleri_files/libs/bootstrap/bootstrap.min.js"></script>
<link href="sss-tumorleri_files/libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="sss-tumorleri_files/libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">


</head>

<body class="fullcontent">

<div id="quarto-content" class="page-columns page-rows-contents page-layout-article">

<main class="content" id="quarto-document-content">



<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri0.jpg" class="img-fluid"></p>
<section id="sss-tumorleri" class="level1">
<h1>SSS Tümörleri</h1>
</section>
<section id="dr.-serdar-balci" class="level1">
<h1>Dr.&nbsp;Serdar BALCI</h1>
</section>
<section id="sss-tümörleri" class="level1">
<h1>SSS Tümörleri</h1>
<ul>
<li><strong>SSS tümörlerinin yıllık insidansı</strong>
<ul>
<li><strong>10-17/100,000 intrakraniyel tümörler</strong></li>
<li><strong>1-2/100,000 intraspinal tümörler</strong></li>
</ul></li>
<li><strong>1/2-2/3 primer tümörler</strong></li>
<li><strong>Diğerleri metastatik</strong></li>
<li><strong>Pediatrik tümörlerin %20’si</strong>
<ul>
<li><strong>Daha çok posterior fossada</strong></li>
</ul></li>
<li><strong>Erişkinlerde tümörler daha çok supratentorial</strong></li>
</ul>
</section>
<section id="sss-tümörlerinin-özellikleri" class="level1">
<h1>SSS Tümörlerinin Özellikleri</h1>
<ul>
<li><strong>Karsinomlar gibi önceden tespit edilebilen in situ ya da premalign evreleri yok</strong></li>
<li><strong>Düşük dereceli lezyonlar beynin geniş alanlarını infiltre edebilir</strong>
<ul>
<li><strong>Ciddi klinik defisit, rezekte edilemez ve kötü prognoz</strong></li>
</ul></li>
<li><strong>Histolojik sınıflamadan bağımsız olarak anatomik lokalizasyon klinik gidişi etkiler</strong>
<ul>
<li><strong>Lokal kitle etkisi</strong>
<ul>
<li><strong>Benign meningiom medullada kardiyorespiratuar arreste neden olur</strong></li>
</ul></li>
<li><strong>Rezektabilite</strong>
<ul>
<li><strong>Beyin kökü gliomları rezeke edilemez</strong></li>
</ul></li>
</ul></li>
<li><strong>En malign gliomlar bile nadiren SSS dışına çıkar</strong>
<ul>
<li><strong>Lokal infiltrasyon</strong></li>
<li><strong>Subaraknoid alana yayılım</strong></li>
</ul></li>
</ul>
</section>
<section id="sss-tümörleri-1" class="level1">
<h1>SSS Tümörleri</h1>
<ul>
<li><strong>SSS tümörleri hemen tüm hücre tiplerinden köken alır</strong></li>
<li><strong>Beyin zarları</strong>
<ul>
<li><strong>Meningiom</strong></li>
</ul></li>
<li><strong>Beyin</strong>
<ul>
<li><strong>Gliom, nöronal tümörler, koroid pleksus tümörleri</strong></li>
</ul></li>
<li><strong>Diğer hücre popülasyonları</strong>
<ul>
<li><strong>Primer SSS lenfomaları, germ hücre tümörleri</strong></li>
</ul></li>
<li><strong>Diğer organlardan</strong>
<ul>
<li><strong>Metastaz</strong></li>
</ul></li>
</ul>
</section>
<section id="sss-tümörleri-sınıflaması" class="level1">
<h1>SSS Tümörleri Sınıflaması</h1>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri1.jpg" class="img-fluid"></p>
</section>
<section id="hücre-orijinine-göre-sınıflama" class="level1">
<h1>Hücre orijinine göre sınıflama</h1>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri2.png" class="img-fluid"></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri3.png" class="img-fluid"></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri4.png" class="img-fluid"></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri5.png" class="img-fluid"></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri6.png" class="img-fluid"></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri7.png" class="img-fluid"></p>
</section>
<section id="ayırıcı-tanı-için-en-önemli-özellikler" class="level1">
<h1>Ayırıcı tanı için en önemli özellikler</h1>
<p><strong>Lokalizasyon, lokalizasyon, lokalizasyon…</strong></p>
<p><strong>Yaş</strong></p>
<p><strong>Radyolojik özellikler</strong></p>
<p><strong>Histomorfolojik özellikler</strong></p>
<p><strong>Genetik özellikler</strong></p>
</section>
<section id="sss-tümörlerinin-lokalizasyonu" class="level1">
<h1>SSS tümörlerinin lokalizasyonu</h1>
<ul>
<li><strong>Spesifik tümörler spesifik lokalizasyonlarda olur</strong>
<ul>
<li><strong>Serebellum → Medulloblastom</strong></li>
<li><strong>İntraventriküler → Santral Nörositom</strong></li>
</ul></li>
<li><strong>Spesifik yaş grupları</strong>
<ul>
<li><strong>Pediatrik → Medulloblastom, Pilositik astrositom</strong></li>
<li><strong>İleri yaş → Glioblastom, Lenfoma</strong></li>
</ul></li>
</ul>
</section>
<section id="sss-tümörlerinin-yayılımı" class="level1">
<h1>SSS tümörlerinin yayılımı</h1>
<p><strong>Beyin tümörlerinin diğer bölgelere yayılımı çok nadir</strong></p>
<p><strong>Spinal subaraknoid tümör yayılımı (ekilimi, seeding)</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri8.png" class="img-fluid"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
</section>
<section id="sss-tümörlerinin-derecelendirilmesi" class="level1">
<h1>SSS tümörlerinin derecelendirilmesi</h1>
<p><strong>Derecelendirme histolojik alt tipe göre yapılır</strong></p>
<p><strong>Grade I tümörler</strong></p>
<p><strong>Grade II tümörler</strong></p>
<p><strong>Grade III tümörler</strong></p>
<p><strong>Grade IV tümörler</strong></p>
<p><strong>Benign, Resection is cure</strong></p>
<p><strong>Progression can be seen</strong></p>
</section>
<section id="gliomlar" class="level1">
<h1>GLIOMLAR</h1>
</section>
<section id="gliomlar-1" class="level1">
<h1>Gliomlar</h1>
<ul>
<li><strong>Beyin parankim tümörleri</strong></li>
<li><strong>Glial hücelere benzerliklerine göre</strong>
<ul>
<li><strong>Astrositom</strong></li>
<li><strong>Oligodendrogliom</strong></li>
<li><strong>Ependimom</strong></li>
</ul></li>
<li><strong>Diffüz, infiltratif gliomlar</strong>
<ul>
<li><strong>En sık görülen tipler</strong></li>
<li><strong>Astrositik, oligodendroglial ve mikst formlar</strong></li>
</ul></li>
<li><strong>Ependimomlar solid kitleler oluştururlar</strong></li>
</ul>
</section>
<section id="grading-of-cns-gliomas" class="level1">
<h1>Grading of CNS gliomas</h1>
<p><strong>Increasing tumor malignancy is associated with more cytologic anaplasia, increased cell density, necrosis, and mitotic activity</strong></p>
<p><strong>Grade I tumors</strong></p>
<p><strong>Grade II tumors</strong></p>
<p><strong>Grade III tumors</strong></p>
<p><strong>Grade IV tumors</strong></p>
</section>
<section id="astrositomlar" class="level1">
<h1>Astrositomlar</h1>
<ul>
<li><strong>Pilositik astrositomlar</strong>
<ul>
<li><strong>Derece I</strong></li>
</ul></li>
<li><strong>İnfiltratif gliomlar</strong>
<ul>
<li><strong>Diffüz Astrositom, Derece II</strong>
<ul>
<li><strong>Atipik nükleer özellikler</strong></li>
<li><strong>İnfiltrasyon</strong></li>
</ul></li>
<li><strong>Anaplastik Astrositom, Derece III</strong>
<ul>
<li><strong>Artmış mitoz</strong></li>
</ul></li>
<li><strong>Glioblastom, Derece IV</strong>
<ul>
<li><strong>Nekroz</strong></li>
<li><strong>Mikrovasküler (endotelial) proliferasyon</strong></li>
</ul></li>
</ul></li>
</ul>
</section>
<section id="pilositik-astrositom-derece-i" class="level1">
<h1>Pilositik Astrositom, Derece I</h1>
<ul>
<li><strong>Benign tümör</strong></li>
<li><strong>Çocuklar ve genç erişkinler</strong></li>
<li><strong>Lokalizasyon</strong>
<ul>
<li><strong>En sık serebellum</strong></li>
<li><strong>3. ventrikül</strong></li>
<li><strong>Optik yolak</strong></li>
<li><strong>Spinal kord</strong></li>
<li><strong>Serebral hemisferler</strong></li>
</ul></li>
<li><strong>Tümör ile ilişkili kist</strong>
<ul>
<li><strong>Rekürrens olurs da kistik komponentin genişlemesi ile olur</strong></li>
</ul></li>
<li><strong>Hipotalamik tümörler problemli çünkü tümüyle rezeke edilemez</strong></li>
</ul>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri9.png" class="img-fluid"></p>
<p><strong>Pilositik Astrositom</strong></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
</section>
<section id="pilositik-astrositom" class="level1">
<h1>Pilositik Astrositom</h1>
<ul>
<li><strong>BRAF (serin-threonin kinaz) aktivasyon mutasyonları</strong>
<ul>
<li><strong>Tandem duplikasyon</strong></li>
<li><strong>Nokta mutasyonu (V600E)</strong></li>
</ul></li>
<li><strong>IDH1 ve IDH2 mutasyon yok</strong></li>
</ul>
<p><strong>Kistik</strong></p>
<p><strong>Kist duvarında mural nodül</strong></p>
<p><strong>Eğer solid ise, iyi sınırlı</strong></p>
<p><strong>Bipolar hücreler, ince saçsı uzantılar</strong></p>
<p><strong>GFAP-pozitif</strong></p>
<p><strong>Rozental lifler, eozinofilik granüler cisimcikler, mikrokist</strong></p>
<p><strong>Nekroz ve mitoz çok çok nadir</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri10.png" class="img-fluid"></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri11.png" class="img-fluid"></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri12.png" class="img-fluid"></p>
</section>
<section id="diffüz-astrositomlar" class="level1">
<h1>Diffüz astrositomlar</h1>
<ul>
<li><strong>Erişkin gliomların %80’i</strong></li>
<li><strong>4-6. dekad</strong></li>
<li><strong>Genellikle serebral hemisferlerde</strong></li>
<li><strong>Klinik bilgi ve bulgular</strong>
<ul>
<li><strong>Nöbet</strong></li>
<li><strong>Başağrısı</strong></li>
<li><strong>Lokalizasyona bağlı nörolojik defisitler</strong></li>
</ul></li>
</ul>
</section>
<section id="diffuse-astrocytoma" class="level1">
<h1>Diffuse Astrocytoma</h1>
<ul>
<li><strong>Spectrum of histologic differentiation that correlates well with clinical course and outcome</strong>
<ul>
<li><strong>well-differentiated astrocytoma (grade II/IV)</strong></li>
<li><strong>anaplastic astrocytoma (grade III/IV)</strong></li>
<li><strong>glioblastoma (grade IV/IV)</strong></li>
</ul></li>
</ul>
<p><strong>Infiltrating pontine glioma (astrocytoma)</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri13.png" class="img-fluid"></p>
<p>Autopsy Pathology: A Manual and Atlas</p>
<p><strong>Diffüz infiltratif astrositom</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri14.png" class="img-fluid"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri15.png" class="img-fluid"></p>
<p><strong>İyi diferansiye astrositomlar belirsiz sınırlı, gri, infiltratif tümörlerdir. Ayrı bir kitle oluşturmadan infiltratif oalrak büyür ve normal dokuların yapısını ortadan kaldırır</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri16.png" class="img-fluid"></p>
<p><strong>Makroskopik olarak görünen sınır ötesine de uzanım mutlaka vardır</strong></p>
<p><strong>Kesit yüzü sert, yumuşak veya jelatinöz</strong></p>
<p><strong>Kistik dejenerasyon görülebilir</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri17.png" class="img-fluid"></p>
<p><strong>Clinical Neuropathology Text and Color Atlas</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri18.png" class="img-fluid"></p>
<p><strong>Practical Surgical Neuropathology</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri19.png" class="img-fluid"></p>
<p><strong>Brain Tumor Pathol (2011) 28:177–183</strong></p>
</section>
<section id="diffüz-astrositom" class="level1">
<h1>Diffüz astrositom</h1>
<ul>
<li><strong>İyi diferansiye astrositomlar uuzn yıllar statik kalabilir</strong>
<ul>
<li><strong>Progresyon olduğunda, ortalama sağkalım 5 yıldan fazla</strong></li>
</ul></li>
<li><strong>Hızlı klinik bozulma, anaplastik özelliklerin ortaya çıkması ve hızlı tümör büyümesi ile korele</strong></li>
<li><strong>Tümörlerin dereceleri artabilir</strong>
<ul>
<li><strong>İyi diferansiye, Grade II → Anaplastik astrositom, grade III → Glioblastom, grade IV</strong></li>
</ul></li>
<li><strong>Glioblastoma ait histolojik özellikler belirgin olduğunda sağkalım çok kötü</strong>
<ul>
<li><strong>Rezeksiyon, radyoterapi ve kemoterapi ile ortanca sağkalım 15 ay</strong></li>
</ul></li>
</ul>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri20.png" class="img-fluid"></p>
<p><strong>Brain Tumor Pathol (2011) 28:177–183</strong></p>
</section>
<section id="defects-in-tricyclic-carbon-cycle" class="level1">
<h1>Defects in tricyclic carbon cycle</h1>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri21.png" class="img-fluid"></p>
<p><strong>Isocitrate dehydrogenase mutasyonları yan ürünlerin birikimine neden olur</strong></p>
<p><strong>SSS tümörlerinde yakın zamanda bulunan en önemli mutasyon</strong></p>
<p><strong>Cancer Cell. 2010 Jan 19;17(1):7-9</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri22.png" class="img-fluid"></p>
<p><strong>N Engl J Med 2009;360:765-73.</strong></p>
</section>
<section id="iyi-diferansiye-astrositom" class="level1">
<h1>İyi diferansiye astrositom</h1>
<p><strong>Glial hücre sayısında hafif orta artış</strong></p>
<p><strong>Değişken nükleer pleomorfizm</strong></p>
<p><strong>Zeminde ince, GFAP pozitif gliofibriler ağ</strong></p>
<p><strong>Normal doku ve tümör geçişi net değil</strong></p>
<p><strong>Neoplastik hücreler ana tümör kitlesinin santimetrelerce uzağında olabilir</strong></p>
</section>
<section id="anaplastik-astrositomlar-derece-iii" class="level1">
<h1>Anaplastik astrositomlar, Derece III</h1>
<p><strong>Selülarite daha belirgin</strong></p>
<p><strong>Daha belirgin nükleer pleomorfizm</strong></p>
<p><strong>Mitotik figürlerin görülmesi</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri23.png" class="img-fluid"></p>
<p><strong>Practical Surgical Neuropathology</strong></p>
</section>
<section id="glioblastom-derece-iv" class="level1">
<h1>Glioblastom, Derece IV</h1>
<ul>
<li><strong>p53 ve Rb tümör süpresör yolaklarında fonksiyon kaybı mutasyonları</strong></li>
<li><strong>Onkojenik PI3K yolaklarında fonksiyon kazanıkm mutasyonları</strong></li>
<li><strong>Düşük dereceli astrositomlarda ve bunlardan gelişen glioblastomlarda isocitrate dehydrogenase (IDH1 and IDH2) mutasyonları</strong>
<ul>
<li><strong>İmmünohistokimya ile tanısal olarak da kullanılıyor</strong></li>
</ul></li>
</ul>
</section>
<section id="glioblastom" class="level1">
<h1>Glioblastom</h1>
<ul>
<li><strong>Anaplastik astrositom özellikleri VE</strong></li>
<li><strong>Nekroz</strong>
<ul>
<li><strong>Psödopalizatlanma</strong></li>
<li><strong>Coğrafi</strong></li>
</ul></li>
<li><strong>Vasküler proliferasyon</strong>
<ul>
<li><strong>Mikrovasküler proliferasyon</strong></li>
<li><strong>Vasküler endotelyal proliferasyon</strong></li>
<li><strong>Glomeruloid vasküler proliferasyon</strong></li>
</ul></li>
</ul>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri24.png" class="img-fluid"></p>
<p><strong>Glioblastom</strong></p>
<p><strong>Nekrotik, hemorajik, infiltratif kitle</strong></p>
<ul>
<li><strong>Makroskopik görünümde bölgesel farklılıklar karakteristiktir:</strong></li>
<li><strong>Sert ve beyaz</strong></li>
<li><strong>Yumuşak ve sarı</strong>
<ul>
<li><strong>Nekroz</strong></li>
</ul></li>
<li><strong>Kistik dejenerasyon ve kanama</strong></li>
</ul>
<p><strong>Robbins Basic Pathology</strong></p>
<p><strong>Glioblastoma multiforme</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri25.png" class="img-fluid"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri26.png" class="img-fluid"></p>
<p><strong>Glioblastom</strong></p>
<p><strong>Selüler tümör, nekroz ve psödopalizatlanma dizilimi</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri27.png" class="img-fluid"></p>
<p><strong>Clinical Neuropathology Text and Color Atlas</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri28.png" class="img-fluid"></p>
<p><strong>Practical Surgical Neuropathology</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri29.png" class="img-fluid"></p>
<p><strong>Practical Surgical Neuropathology</strong></p>
</section>
<section id="oligodendrogliom" class="level1">
<h1>OLIGODENDROGLIOM</h1>
</section>
<section id="oligodendrogliom-1" class="level1">
<h1>Oligodendrogliom</h1>
<ul>
<li><strong>Gliomların %5-15’i</strong></li>
<li><strong>4-5. dekad</strong></li>
<li><strong>Uzun yıllar süren nörolojik bulgular, sıklıkla nöbet</strong></li>
<li><strong>Çoğunlukla serebral hemisferlerde</strong>
<ul>
<li><strong>Frontal ve temporal lob</strong></li>
</ul></li>
</ul>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri30.png" class="img-fluid"></p>
<p><strong>Oligodendrogliom: Tümör hücreleri yuvarlak oval çekirdekli, sitoplazmik halo</strong></p>
<p><strong>Damarlar ince</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<ul>
<li><strong>Benzer dereceli astrositomdan daha iyi prognozlu</strong></li>
<li><strong>Cerrahi, kemoterapi ve radyoterapi sonrası</strong>
<ul>
<li><strong>İyi diferansiye (WHO grade II) oligodendrogliomlarda ortalama sağkalım 10-20 yıl</strong></li>
<li><strong>Anaplastik (WHO grade III) oligodendrogliomlarda 5-10 yıl</strong></li>
</ul></li>
</ul>
<p><strong>1p ve 19q kromozomların kaybı</strong></p>
<p><strong>1p ve 19q kaybı tipik olarak birlikte olur</strong></p>
<p><strong>1p ve 19q kaybı gösteren tümörlerde kemoterapi ve radyoterapiye cevap çok daha iyi</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri31.png" class="img-fluid"></p>
</section>
<section id="iyi-diferansiye-oligodendrogliomlar-who-grade-iiiv" class="level1">
<h1>İyi diferansiye oligodendrogliomlar(WHO grade II/IV)</h1>
<ul>
<li><strong>Infiltratif tümörler</strong></li>
<li><strong>Jelatinöz, gri kitleler</strong></li>
<li><strong>Kist, fokal kanama ve kalsifikasyon</strong></li>
<li><strong>Tabakalar halinde regüler hücreler</strong>
<ul>
<li><strong>Oligodendroglial hücrelere benzer yuvarlak nükleus, ince granüler görünümde kromatin</strong></li>
<li><strong>Şeffaf sitoplazmik halo</strong></li>
</ul></li>
<li><strong>İnce anastomoz yapan kapillerler</strong></li>
<li><strong>Kalsifikasyon</strong>
<ul>
<li><strong>Tümörlerin %90’ında var</strong></li>
<li><strong>Mikroskopik ve makroskopik birikimler</strong></li>
</ul></li>
<li><strong>Mitozu genelde tespit etmek zor</strong></li>
</ul>
</section>
<section id="anaplastic-oligodendroglioma-who-grade-iiiiv" class="level1">
<h1>Anaplastic oligodendroglioma (WHO grade III/IV)</h1>
<p><strong>More aggressive subtype</strong></p>
<p><strong>Higher cell density</strong></p>
<p><strong>Nuclear anaplasia</strong></p>
<p><strong>Mitotic activity</strong></p>
</section>
<section id="ependimom" class="level1">
<h1>EPENDİMOM</h1>
</section>
<section id="ependimom-1" class="level1">
<h1>Ependimom</h1>
<ul>
<li><strong>Oluşum yeri</strong>
<ul>
<li><strong>Ependim döşeli ventriküler sistem</strong></li>
<li><strong>Central canal</strong></li>
</ul></li>
<li><strong>İlk iki dekad</strong>
<ul>
<li><strong>4. ventrikül</strong></li>
<li><strong>Bu yaş grubundaki beyin tümörlerinin %5-10’u</strong></li>
</ul></li>
<li><strong>Erişkinler</strong>
<ul>
<li><strong>Spinal kord en sık oluşum yeri</strong></li>
<li><strong>Nörofibromatozis tip 2</strong></li>
</ul></li>
<li><strong>Tümüyle çıkarılan supratentoryal ve spinal ependimomların prognozu posterior fossa tümörlerinden daha iyi</strong></li>
</ul>
<p><strong>4. ventrikül</strong></p>
<p><strong>Solid veya papiller kitle</strong></p>
<p><strong>Ventrikül tabanından köken alır</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri32.png" class="img-fluid"></p>
</section>
<section id="ependymoma" class="level1">
<h1>Ependymoma</h1>
<ul>
<li><strong>Cells with regular, round to oval nuclei and abundant granular chromatin</strong></li>
<li><strong>Between the nuclei a variably dense fibrillary background</strong></li>
<li><strong>Round or elongated structures</strong>
<ul>
<li><strong>rosettes, canals</strong></li>
<li><strong>resemble the embryologic ependymal canal</strong></li>
</ul></li>
<li><strong>Long, delicate processes extending into a lumen</strong></li>
<li><strong>Perivascular pseudorosettes</strong>
<ul>
<li><strong>tumor cells are arranged around vessels with an intervening zone containing thin ependymal processes</strong></li>
</ul></li>
</ul>
</section>
<section id="anaplastic-ependymoma" class="level1">
<h1>Anaplastic ependymoma</h1>
<p><strong>Increased cell density</strong></p>
<p><strong>High mitotic rates</strong></p>
<p><strong>Necrosis</strong></p>
<p><strong>Less evident ependymal differentiation</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri33.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="neuronal-tumors" class="level1">
<h1>NEURONAL TUMORS</h1>
</section>
<section id="neuronal-tümörler" class="level1">
<h1>Neuronal Tümörler</h1>
<p><strong>Santral Nörositom</strong></p>
<p><strong>Gangliogliom</strong></p>
<p><strong>Dysembryoplastic neuroepithelial tumor (DNET)</strong></p>
</section>
<section id="central-neurocytoma" class="level1">
<h1>Central neurocytoma</h1>
<p><strong>Low-grade neoplasm</strong></p>
<p><strong>Within and adjacent to the ventricular system</strong></p>
<p><strong>Most commonly the lateral or third ventricles</strong></p>
<p><strong>Evenly spaced, round, uniform nuclei</strong></p>
<p><strong>Islands of neuropil</strong></p>
</section>
<section id="ganglioglioma" class="level1">
<h1>Ganglioglioma</h1>
<ul>
<li><strong>Manifest with seizures</strong></li>
<li><strong>Slow-growing</strong></li>
<li><strong>Mixed tumor</strong>
<ul>
<li><strong>glial elements</strong>
<ul>
<li><strong>low-grade astrocytoma</strong></li>
</ul></li>
<li><strong>mature-appearing neurons</strong></li>
</ul></li>
<li><strong>Glial component occasionally becomes anaplastic</strong>
<ul>
<li><strong>then progresses rapidly</strong></li>
</ul></li>
</ul>
</section>
<section id="dysembryoplastic-neuroepithelial-tumor-dnet" class="level1">
<h1>Dysembryoplastic neuroepithelial tumor (DNET)</h1>
<ul>
<li><strong>Low-grade childhood tumor</strong></li>
<li><strong>Grows slowly</strong></li>
<li><strong>Relatively good prognosis after resection</strong></li>
<li><strong>Often manifests as a seizure disorder</strong></li>
<li><strong>Typically located in the superficial temporal lobe</strong></li>
<li><strong>Consists of small round neuronal cells</strong>
<ul>
<li><strong>arranged in columns</strong></li>
<li><strong>around central cores of processes</strong></li>
</ul></li>
<li><strong>Typically form multiple discrete intracortical nodules</strong>
<ul>
<li><strong>myxoid background</strong></li>
</ul></li>
<li><strong>Well-differentiated “floating” neurons within pools of mucopolysaccharide-rich myxoid fluid</strong></li>
</ul>
</section>
<section id="embriyonal-primitif-neoplaziler" class="level1">
<h1>EMBRİYONAL (PRIMITIF) NEOPLAZİLER</h1>
</section>
<section id="embryonal-primitive-neoplasms" class="level1">
<h1>Embryonal (Primitive) Neoplasms</h1>
<ul>
<li><strong>Neuroectodermal origin</strong></li>
<li><strong>Primitive “small round cell” appearance</strong>
<ul>
<li><strong>reminiscent of normal progenitor cells encountered in the developing CNS</strong></li>
</ul></li>
<li><strong>Differentiation is often limited</strong></li>
<li><strong>May progress along multiple lineages</strong></li>
</ul>
</section>
<section id="medulloblastom" class="level1">
<h1>Medulloblastom</h1>
<p><strong>En sık embriyonel tümör</strong></p>
<p><strong>Pediatrik beyin tümörlerinin %20’si</strong></p>
<p><strong>Serebellum</strong></p>
<p><strong>Küçük yuvarlak hücreli malign tümör</strong></p>
<ul>
<li><strong>Most common Embryonal (Primitive) Neoplasm</strong></li>
<li><strong>20% of pediatric brain tumors</strong></li>
<li><strong>Cerebellum</strong></li>
<li><strong>Neuronal and glial markers are nearly always expressed</strong></li>
<li><strong>Highly malignant</strong>
<ul>
<li><strong>Prognosis for untreated patients is dismal</strong></li>
<li><strong>Exquisitely radiosensitive</strong></li>
<li><strong>Total excision, chemotherapy, and irradiation, the 5-year survival rate may be as high as 75%</strong></li>
</ul></li>
<li><strong>Primitive neuroectodermal tumors (PNETs)</strong>
<ul>
<li><strong>Tumors of similar histologic type and a poor degree of differentiation elsewhere in the nervous system</strong></li>
</ul></li>
</ul>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri34.png" class="img-fluid"></p>
<p><strong>Located in the midline of the cerebellum</strong></p>
<p><strong>Lateral tumors occur more often in adults</strong></p>
<p><strong>Often well circumscribed, gray, and friable</strong></p>
<p><strong>May extend to the surface of the cerebellar folia and involve the leptomeninges</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri35.png" class="img-fluid"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri36.png" class="img-fluid"></p>
<p><strong>Extremely cellular</strong></p>
<p><strong>Sheets of anaplastic (small blue) cells</strong></p>
<p><strong>Small, with little cytoplasm</strong></p>
<p><strong>Hyperchromatic nuclei</strong></p>
<p><strong>Abundant mitosis</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri37.png" class="img-fluid"></p>
<p><strong>Focal neuronal differentiation</strong></p>
<p><strong>Homer Wright or neuroblastic rosette</strong></p>
<p><strong>Resembles the rosettes in neuroblastomas</strong></p>
<p><strong>Primitive tumor cells surrounding central neuropil</strong></p>
<p><strong>-delicate pink material formed by neuronal processes</strong></p>
</section>
<section id="medulloblastom-genetiği" class="level1">
<h1>Medulloblastom genetiği</h1>
<ul>
<li><strong>MYC amplifikasyonu</strong>
<ul>
<li><strong>Kötü klinik gidiş</strong></li>
</ul></li>
<li><strong>WNT sinyal yolağı</strong>
<ul>
<li><strong>Daha iyi gidiş</strong></li>
</ul></li>
<li><strong>Sonic hedgehog (shh) yolağı</strong>
<ul>
<li><strong>Klinik gidişle ilişkisi net değil</strong></li>
</ul></li>
</ul>
</section>
<section id="genetic-of-medulloblastoma" class="level1">
<h1>Genetic of medulloblastoma</h1>
<ul>
<li><strong>Morphologically similar tumors commonly exhibit distinct alterations</strong></li>
<li><strong>There is a relationship between the underlying mutations and outcome</strong></li>
<li><strong>MYC amplification</strong>
<ul>
<li><strong>associated with poor outcomes</strong></li>
</ul></li>
<li><strong>WNT signaling pathway</strong>
<ul>
<li><strong>have a more favorable course</strong></li>
</ul></li>
<li><strong>Sonic hedgehog (shh) pathway</strong>
<ul>
<li><strong>has a critical role in tumorigenesis but an uncertain relationship to outcome</strong></li>
</ul></li>
</ul>
</section>
<section id="lenfomalar" class="level1">
<h1>LENFOMALAR</h1>
</section>
<section id="primary-cns-lymphoma" class="level1">
<h1>Primary CNS Lymphoma</h1>
<ul>
<li><strong>Mostly diffuse large B cell lymphoma</strong></li>
<li><strong>2% of extranodal lymphomas</strong></li>
<li><strong>1% of intracranial tumors</strong></li>
<li><strong>Most common CNS neoplasm in immunosuppressed persons</strong>
<ul>
<li><strong>nearly always positive for the oncogenic Epstein-Barr virus</strong></li>
</ul></li>
<li><strong>Nonimmunosuppressed populations</strong>
<ul>
<li><strong>age spectrum is relatively wide</strong></li>
<li><strong>incidence increasing &gt;60 years of age</strong></li>
</ul></li>
<li><strong>Aggressive disease</strong>
<ul>
<li><strong>relatively poor response to chemotherapy compared with peripheral lymphomas</strong></li>
</ul></li>
</ul>
</section>
<section id="primer-sss-lenfoması" class="level1">
<h1>Primer SSS lenfoması</h1>
<p><strong>Çoğunlukla diffüz büyük B hücreli lenfoma</strong></p>
</section>
<section id="primary-cns-lymphoma-1" class="level1">
<h1>Primary CNS Lymphoma</h1>
<ul>
<li><strong>Multiple tumor nodules within the brain parenchyma</strong></li>
<li><strong>Involvement outside of the CNS is an uncommon late complication</strong></li>
<li><strong>Lymphoma originating outside the CNS rarely spreads to the brain parenchyma</strong>
<ul>
<li><strong>when it happens, within the CSF or involvement of the meninges</strong></li>
</ul></li>
<li><strong>Often involve deep gray structures</strong></li>
<li><strong>Also white matter and the cortex</strong></li>
<li><strong>Periventricular spread is common</strong></li>
<li><strong>Relatively well defined as compared with glial neoplasms</strong>
<ul>
<li><strong>not as discrete as metastases</strong></li>
</ul></li>
<li><strong>EBV-associated tumors</strong>
<ul>
<li><strong>extensive areas of necrosis</strong></li>
</ul></li>
<li><strong>Nearly always aggressive large B-cell lymphomas</strong>
<ul>
<li><strong>rarely other histologic types</strong></li>
</ul></li>
<li><strong>Malignant cells accumulate around blood vessels</strong></li>
<li><strong>Infiltrate the surrounding brain parenchyma</strong></li>
</ul>
</section>
<section id="germ-cell-tumors" class="level1">
<h1>GERM CELL TUMORS</h1>
</section>
<section id="primary-brain-germ-cell-tumors" class="level1">
<h1>Primary brain germ cell tumors</h1>
<ul>
<li><strong>Occur along the midline</strong>
<ul>
<li><strong>Most commonly in the pineal and the suprasellar regions</strong></li>
</ul></li>
<li><strong>0.2-1% of brain tumors in European</strong></li>
<li><strong>10% of brain tumors in Japanese</strong></li>
<li><strong>Young</strong>
<ul>
<li><strong>90%, during the first 2 decades of life</strong></li>
</ul></li>
<li><strong>Pineal region show a strong male predominance</strong></li>
<li><strong>Germinoma</strong>
<ul>
<li><strong>Most common primary CNS germ cell tumor</strong></li>
<li><strong>resembles testicular seminoma</strong></li>
</ul></li>
<li><strong>Metastatic gonadal germ cell tumors also occur</strong></li>
</ul>
</section>
<section id="meningiom" class="level1">
<h1>MENINGIOM</h1>
</section>
<section id="meningioma" class="level1">
<h1>Meningioma</h1>
<p><strong>Benign</strong></p>
<p><strong>Araknoid meningotelyal hücre kökenli</strong></p>
<p><strong>Duraya yapışık</strong></p>
<ul>
<li><strong>Predominantly benign tumors</strong></li>
<li><strong>Arise from arachnoid meningothelial cells</strong></li>
<li><strong>Usually occur in adults</strong></li>
<li><strong>Often attached to the dura</strong></li>
<li><strong>Found along any of the external surfaces of the brain</strong></li>
<li><strong>Within the ventricular system</strong>
<ul>
<li><strong>arise from the stromal arachnoid cells of the choroid plexus</strong></li>
</ul></li>
<li><strong>Sympotoms</strong>
<ul>
<li><strong>vague nonlocalizing symptoms</strong></li>
<li><strong>focal findings compression of adjacent brain</strong></li>
</ul></li>
<li><strong>Most meningiomas are easily separable from underlying brain</strong>
<ul>
<li><strong>some tumors infiltrate the brain</strong></li>
<li><strong>increased risk of recurrence</strong></li>
</ul></li>
<li><strong>Overall prognosis</strong>
<ul>
<li><strong>lesion size and location</strong></li>
<li><strong>surgical accessibility</strong></li>
<li><strong>histologic grade</strong></li>
</ul></li>
<li><strong>Neurofibromatosis type 2 (NF2)</strong>
<ul>
<li><strong>Multiple meningiomas</strong></li>
<li><strong>eighth-nerve schwannomas</strong></li>
<li><strong>glial tumors</strong></li>
</ul></li>
<li><strong>Half of meningiomas not associated with NF2</strong>
<ul>
<li><strong>acquired loss-of-function mutations in the NF2 TSG on 22q</strong></li>
</ul></li>
<li><strong>Mutations found in all grades of meningioma</strong>
<ul>
<li><strong>involved with tumor initiation</strong></li>
</ul></li>
<li><strong>Mutations in NF2 are more common in:</strong>
<ul>
<li><strong>fibroblastic, transitional, and psammomatous growth pattern</strong></li>
</ul></li>
</ul>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri38.png" class="img-fluid"></p>
<p><strong>Meningioma</strong></p>
<p><strong>WHO grade I/IV</strong></p>
<p><strong>well-defined dura-based masses</strong></p>
<p><strong>compress the brain but do not invade it</strong></p>
<p><strong>Extension into the overlying bone may be present</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><strong>Parasagittal meningioma</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri39.png" class="img-fluid"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><strong>Intraosseous meningioma</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri40.png" class="img-fluid"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
</section>
<section id="histologic-patterns-of-meningioma" class="level1">
<h1>Histologic patterns of Meningioma</h1>
<ul>
<li><strong>Syncytial</strong>
<ul>
<li><strong>whorled clusters of cells without visible cell membranes that sit in tight groups</strong></li>
</ul></li>
<li><strong>Fibroblastic</strong>
<ul>
<li><strong>elongated cells and abundant collagen deposition between them</strong></li>
</ul></li>
<li><strong>Transitional</strong>
<ul>
<li><strong>shares features of the syncytial and fibroblastic types</strong></li>
</ul></li>
<li><strong>Psammomatous</strong>
<ul>
<li><strong>numerous psammoma bodies</strong></li>
</ul></li>
<li><strong>Secretory</strong>
<ul>
<li><strong>gland-like PAS-positive eosinophilic secretions known as pseudopsammoma bodies</strong></li>
</ul></li>
</ul>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri41.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="atypical-meningiomas-who-grade-iiiv" class="level1">
<h1>Atypical meningiomas(WHO grade II/IV)</h1>
<p><strong>prominent nucleoli</strong></p>
<p><strong>increased cellularity</strong></p>
<p><strong>pattern-less growth</strong></p>
<p><strong>higher mitotic rate</strong></p>
<p><strong>More aggressive local growth</strong></p>
<p><strong>Higher rate of recurrence</strong></p>
<p><strong>Require therapy in addition to surgery</strong></p>
</section>
<section id="anaplastic-malignant-meningiomas-who-grade-iiiiv" class="level1">
<h1>Anaplastic (malignant) meningiomas(WHO grade III/IV)</h1>
<p><strong>Highly aggressive tumors</strong></p>
<p><strong>May resemble a high-grade sarcoma or carcinoma</strong></p>
<p><strong>usually some histologic evidence of a meningothelial cell origin</strong></p>
</section>
<section id="metastatik-tümörler" class="level1">
<h1>METASTATIK TÜMÖRLER</h1>
</section>
<section id="metastatic-tumors" class="level1">
<h1>Metastatic Tumors</h1>
<p><strong>Mostly carcinomas</strong></p>
<p><strong>1/4-1/2 of intracranial tumors</strong></p>
<p><strong>Most common primary sites</strong></p>
<p><strong>Lung, breast, skin (melanoma), kidney, and gastrointestinal tract</strong></p>
<p><strong>Form sharply demarcated masses</strong></p>
<p><strong>Often at the gray-white junction, and elicit edema</strong></p>
<p><strong>The boundary between tumor and brain parenchyma is sharp at the microscopic level as well, with surrounding reactive gliosis</strong></p>
<p><strong>Direct and localized effects</strong></p>
</section>
<section id="section" class="level1">
<h1></h1>
<p><strong>Metastatic spread of brain tumors to other regions of the body is rare</strong></p>
<p><strong>Brain is not protected against spread of distant tumors</strong></p>
<p><strong>Carcinomas are the dominant type of systemic tumors that metastasize to the nervous system</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri42.png" class="img-fluid"></p>
<p><strong>Metastatic melanoma</strong></p>
<p><strong>Metastatic lesions are distinguished grossly from most primary central nervous system tumors by their multicentricity and well-demarcated margins</strong></p>
<p><strong>The dark color of the tumor nodules in this specimen is due to the presence of melanin</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="paraneoplastic-syndromes" class="level1">
<h1>Paraneoplastic syndromes</h1>
<ul>
<li><strong>Subacute cerebellar degeneration</strong>
<ul>
<li><strong>result in ataxia</strong></li>
<li><strong>destruction of Purkinje cells, gliosis, and a mild inflammatory infiltrate</strong></li>
</ul></li>
<li><strong>Limbic encephalitis</strong>
<ul>
<li><strong>subacute dementia</strong></li>
<li><strong>perivascular inflammatory cells, microglial nodules, some neuronal loss, and gliosis, all centered in the medial temporal lobe</strong></li>
</ul></li>
<li><strong>Subacute sensory neuropathy</strong>
<ul>
<li><strong>altered pain sensation</strong></li>
<li><strong>loss of sensory neurons from dorsal root ganglia, in association with inflammation</strong></li>
</ul></li>
<li><strong>Syndrome of rapid-onset psychosis, catatonia, epilepsy, and coma</strong>
<ul>
<li><strong>associated with ovarian teratoma</strong></li>
<li><strong>antibodies against the N-methyl-d-aspartate (NMDA) receptor</strong></li>
</ul></li>
</ul>
</section>
<section id="ailesel-tümör-sendromlari" class="level1">
<h1>AILESEL TÜMÖR SENDROMLARI</h1>
</section>
<section id="ailesel-tümör-sendromları" class="level1">
<h1>Ailesel tümör sendromları</h1>
<ul>
<li><strong>Tuberous Sclerosis (TSC)</strong>
<ul>
<li><strong>Kortikal tüberler</strong></li>
</ul></li>
<li><strong>von Hippel–Lindau Hastalığı</strong>
<ul>
<li><strong>Serebellar Hemanjioblastomlar</strong></li>
</ul></li>
</ul>
</section>
<section id="tuberous-sclerosis-tsc" class="level1">
<h1>Tuberous Sclerosis (TSC)</h1>
<ul>
<li><strong>Autosomal dominant</strong></li>
<li><strong>Development of hamartomas and benign neoplasms involving the brain and other tissues</strong></li>
<li><strong>CNS hamartomas</strong>
<ul>
<li><strong>cortical tubers</strong></li>
<li><strong>subependymal hamartomas</strong></li>
<li><strong>tumefactive form known as subependymal giant cell astrocytoma</strong></li>
</ul></li>
<li><strong>Proximity to the foramen of Monro</strong>
<ul>
<li><strong>present acutely with obstructive hydrocephalus</strong></li>
<li><strong>requires surgical intervention and/or therapy with an mTOR inhibitor</strong></li>
</ul></li>
<li><strong>Seizures</strong>
<ul>
<li><strong>associated with cortical tubers</strong></li>
<li><strong>difficult to control with antiepileptic drugs</strong></li>
</ul></li>
<li><strong>Extracerebral lesions</strong>
<ul>
<li><strong>renal angiomyolipomas</strong></li>
<li><strong>retinal glial hamartomas</strong></li>
<li><strong>pulmonary lymphangiomyomatosis</strong></li>
<li><strong>cardiac rhabdomyomas</strong></li>
<li><strong>Cysts</strong>
<ul>
<li><strong>liver, kidneys, and pancreas</strong></li>
</ul></li>
<li><strong>Cutaneous lesions</strong>
<ul>
<li><strong>angiofibromas, leathery thickenings in localized patches (shagreen patches), hypopigmented areas (ash leaf patches), and subungual fibromas</strong></li>
</ul></li>
</ul></li>
<li><strong>TSC1</strong>
<ul>
<li><strong>encodes hamartin</strong></li>
</ul></li>
<li><strong>TSC2</strong>
<ul>
<li><strong>encodes tuberin</strong></li>
</ul></li>
<li><strong>Two TSC proteins form a dimeric complex</strong>
<ul>
<li><strong>negatively regulates mTOR, a kinase that “senses” the cell’s nutrient status and regulates cellular metabolism</strong></li>
</ul></li>
<li><strong>Loss of either protein leads to increased mTOR activity</strong>
<ul>
<li><strong>Disrupts nutritional signaling and increases cell growth</strong></li>
</ul></li>
<li><strong>Cortical hamartomas</strong></li>
<li><strong>Firmer than normal cortex</strong></li>
<li><strong>Likened in appearance to potatoes</strong>
<ul>
<li><strong>“tubers”</strong></li>
</ul></li>
<li><strong>Composed of haphazardly arranged large neurons</strong></li>
<li><strong>Lack the normal cortical laminar architecture</strong></li>
<li><strong>Cells exhibit a mixture of glial and neuronal features</strong>
<ul>
<li><strong>large vesicular nuclei with nucleoli (like neurons)</strong></li>
<li><strong>abundant eosinophilic cytoplasm (like gemistocytic astrocytes)</strong></li>
<li><strong>Similar cells are present in the subependymal nodules</strong></li>
</ul></li>
</ul>
</section>
<section id="von-hippellindau-disease" class="level1">
<h1>von Hippel–Lindau Disease</h1>
<ul>
<li><strong>Autosomal dominant disorder</strong></li>
<li><strong>Hemangioblastoma</strong>
<ul>
<li><strong>cerebellar hemispheres, retina, and, less commonly, the brain stem, spinal cord, and nerve roots</strong></li>
</ul></li>
<li><strong>Cysts</strong>
<ul>
<li><strong>pancreas, liver, and kidneys</strong></li>
</ul></li>
<li><strong>Renal cell carcinoma</strong></li>
<li><strong>Frequency is 1/30,000-40,000</strong></li>
<li><strong>Therapy is directed at the symptomatic neoplasms</strong>
<ul>
<li><strong>surgical resection of cerebellar tumors and laser ablation of retinal tumors</strong></li>
</ul></li>
<li><strong>Tumor suppressor VHL</strong></li>
<li><strong>Encodes a protein that is part of a ubiquitin-ligase complex</strong></li>
<li><strong>Targets the transcription factor hypoxia-inducible factor (HIF) for degradation</strong></li>
<li><strong>Lost all VHL protein function</strong></li>
<li><strong>Express high levels of HIF</strong></li>
<li><strong>Expression of VEGF, various growth factors</strong></li>
<li><strong>Expression of erythropoietin</strong>
<ul>
<li><strong>paraneoplastic polycythemia</strong></li>
</ul></li>
<li><strong>Cerebellar capillary hemangioblastoma</strong>
<ul>
<li><strong>Highly vascular neoplasm</strong></li>
<li><strong>Mural nodule</strong></li>
<li><strong>Large, fluid-filled cyst</strong></li>
<li><strong>Numerous capillary-sized or somewhat larger thin-walled vessels</strong></li>
<li><strong>Intervening stromal cells with vacuolated, lightly PAS-positive, lipid-rich cytoplasm</strong></li>
</ul></li>
</ul>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri43.png" class="img-fluid"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri44.png" class="img-fluid"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><span style="color:#E72E09">Distribution of CNS Tumors</span></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri45.jpg" class="img-fluid"></p>
<p><strong>A pilocytic astrocytoma of the cerebellum in a child. </strong></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri46.jpg" class="img-fluid"></p>
<p><strong>Glioma of the brainstem – pilocytic astrocytoma</strong></p>
</section>
<section id="gbm.-note-the-prominent-vascularity-as-well-as-the-area-of-necrosis-at-the-left-with-neoplastic-cells-palisading-around-it-pseudopalisading-necrosis." class="level1">
<h1>GBM. Note the prominent vascularity as well as the area of necrosis at the left with neoplastic cells palisading around it (pseudopalisading necrosis*).</h1>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri47.jpg" class="img-fluid"></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri48.jpg" class="img-fluid"></p>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri49.jpg" class="img-fluid"></p>
</section>
<section id="here-is-an-ependymoma-arising-from-the-ependymal-lining-of-the-fourth-ventricle-above-the-brainstem-and-bulging-toward-the-cerebellum." class="level1">
<h1>Here is an ependymoma arising from the ependymal lining of the fourth ventricle above the brainstem and bulging toward the cerebellum.</h1>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri50.jpg" class="img-fluid"></p>
</section>
<section id="this-horizontal-ct-scan-section-of-the-brain-reveals-a-large-ependymoma-of-the-fourth-ventricle." class="level1">
<h1>This horizontal (CT scan) section of the brain reveals a large ependymoma of the fourth ventricle.</h1>
<p><img src="img%5CSSS-T%C3%BCm%C3%B6rleri51.jpg" class="img-fluid"></p>
</section>
<section id="irregular-posterior-fossa-mass-medulloblastoma---near-the-midline-of-the-cerebellum-and-extending-into-the-fourth-ventricle-above-the-brainstem" class="level1">
<h1>Irregular posterior fossa mass (medulloblastoma) - near the midline of the cerebellum and extending into the fourth ventricle above the brainstem</h1>
</section>

</main>
<!-- /main column -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const isCodeAnnotation = (el) => {
    for (const clz of el.classList) {
      if (clz.startsWith('code-annotation-')) {                     
        return true;
      }
    }
    return false;
  }
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    text: function(trigger) {
      const codeEl = trigger.previousElementSibling.cloneNode(true);
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
      let selectedAnnoteEl;
      const selectorForAnnotation = ( cell, annotation) => {
        let cellAttr = 'data-code-cell="' + cell + '"';
        let lineAttr = 'data-code-annotation="' +  annotation + '"';
        const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
        return selector;
      }
      const selectCodeLines = (annoteEl) => {
        const doc = window.document;
        const targetCell = annoteEl.getAttribute("data-target-cell");
        const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
        const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
        const lines = annoteSpan.getAttribute("data-code-lines").split(",");
        const lineIds = lines.map((line) => {
          return targetCell + "-" + line;
        })
        let top = null;
        let height = null;
        let parent = null;
        if (lineIds.length > 0) {
            //compute the position of the single el (top and bottom and make a div)
            const el = window.document.getElementById(lineIds[0]);
            top = el.offsetTop;
            height = el.offsetHeight;
            parent = el.parentElement.parentElement;
          if (lineIds.length > 1) {
            const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
            const bottom = lastEl.offsetTop + lastEl.offsetHeight;
            height = bottom - top;
          }
          if (top !== null && height !== null && parent !== null) {
            // cook up a div (if necessary) and position it 
            let div = window.document.getElementById("code-annotation-line-highlight");
            if (div === null) {
              div = window.document.createElement("div");
              div.setAttribute("id", "code-annotation-line-highlight");
              div.style.position = 'absolute';
              parent.appendChild(div);
            }
            div.style.top = top - 2 + "px";
            div.style.height = height + 4 + "px";
            let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
            if (gutterDiv === null) {
              gutterDiv = window.document.createElement("div");
              gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
              gutterDiv.style.position = 'absolute';
              const codeCell = window.document.getElementById(targetCell);
              const gutter = codeCell.querySelector('.code-annotation-gutter');
              gutter.appendChild(gutterDiv);
            }
            gutterDiv.style.top = top - 2 + "px";
            gutterDiv.style.height = height + 4 + "px";
          }
          selectedAnnoteEl = annoteEl;
        }
      };
      const unselectCodeLines = () => {
        const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
        elementsIds.forEach((elId) => {
          const div = window.document.getElementById(elId);
          if (div) {
            div.remove();
          }
        });
        selectedAnnoteEl = undefined;
      };
      // Attach click handler to the DT
      const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
      for (const annoteDlNode of annoteDls) {
        annoteDlNode.addEventListener('click', (event) => {
          const clickedEl = event.target;
          if (clickedEl !== selectedAnnoteEl) {
            unselectCodeLines();
            const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
            if (activeEl) {
              activeEl.classList.remove('code-annotation-active');
            }
            selectCodeLines(clickedEl);
            clickedEl.classList.add('code-annotation-active');
          } else {
            // Unselect the line
            unselectCodeLines();
            clickedEl.classList.remove('code-annotation-active');
          }
        });
      }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
</div> <!-- /content -->



</body></html>